| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 21.64 | -0.17 (-0.78%) | 16.09 - 21.81 | 0.0 |
Market data as of 6:05PM 05/22/13. Quotes are delayed by at least 15 min.
The investment seeks long-term capital growth. The fund normally invests at least 80% of its total assets in equity securities of non-U.S. issuers. Under normal circumstances, its assets will be invested in securities of companies domiciled in at least three different foreign countries. Generally, the fund's investments in any country are limited to 25% or less of its total assets. It may invest without limitation in securities of issuers located in countries with emerging economies or securities markets, but will not invest more than 25% of its total assets in securities of issuers located in any one such country.
| Total Return | 12.67% |
|---|---|
| Yield (Trailing 12 Mo.) | 1.93% |
| Expense Ratio | 1.01% |
| Front Load | None |
| Deferred Load | None |
| Minimum Investment | $5,000,000 |
| Management Tenure | 5 Years |
| Fund Inception | 04/15/2009 |
| Timeframe | INVYX | S&P 500 | Foreign Large Blend |
|---|---|---|---|
| 1 Month | 4.29% | 1.93% | 3.94% |
| 3 Month | 5.49% | 7.18% | 3.84% |
| Year-to-Date | 10.27% | 12.74% | 7.77% |
| 1 Year | 17.78% | 16.89% | 15.45% |
| 3 Year | 6.13% | 12.80% | 6.55% |
| 5 Year | -2.36% | 5.21% | -1.30% |
| 10 Year | 7.46% | 7.88% | 8.69% |
| Since Inception | 12.67% | 10.38% | -- |
| Basic Materials | 11.71% | |
|---|---|---|
| Consumer Cyclical | 12.79% | |
| Financial Services | 20.49% | |
| Real Estate | 1.32% | |
| Consumer Defensive | 5.75% | |
| Healthcare | 12.55% | |
| Utilities | 1.39% | |
| Communication Services | 2.19% | |
| Energy | 7.62% | |
| Industrials | 15.94% | |
| Technology | 8.26% |
| By Percent | Short | 0% | Long | Net | |
|---|---|---|---|---|---|
| Stock | -- | 3.14 | 3.14 | ||
| Bond | -- | 0.00 | 0.00 | ||
| Other | -- | 0.02 | 0.02 | ||
| Foreign Stock | -- | 93.15 | 93.15 | ||
| Foreign Bond | -- | 0.53 | 0.53 | ||
| Total | -- | 96.84 | 96.84 | ||
| Cash | -- | 3.17 | 3.17 | ||
| Total Net Assets | $344.24M |
|---|---|
| Total Stock Holdings | 92 |
| Total Bond Holdings | 1 |
| Company | YTD Return | % of Assets |
|---|---|---|
| Novartis AG | 17.50% | 2.72% |
| Roche Holding AG | 23.65% | 2.32% |
| China Construction Bank Corp H Shares | -- | 2.14% |
| Compagnie Financiere Richemont SA | -- | 2.03% |
| Sekisui Chemical Co., Ltd. | -- | 1.83% |
| SSNHY | -- | 1.77% |
| Bridgestone Corporation | -- | 1.72% |
| Allianz SE | 7.19% | 1.72% |
| AstraZeneca PLC | -- | 1.69% |
| GlaxoSmithKline PLC | 20.09% | 1.66% |
| Valuation | INVYX | Category Range |
|---|---|---|
| Price/Earnings | 13.00 | |
| Price/Book | 1.57 | |
| Price/Sales | 0.89 | |
| Price/Cash Flow | 8.24 | |
| Dividend Yield | 3.02 | |
| LT Earnings | 9.88 | |
| Historical Earnings | 9.57 | |
| Sales Growth | 5.37 | |
| Cash-Flow Growth | 1.46 | |
| Book-Value Growth | 6.25 |
| Management Style | |||
|---|---|---|---|
| Large Cap | |||
| Medium Cap | |||
| Small Cap | |||
 |  |  |
| Rating | vs Category | |
|---|---|---|
| Overall |  | |
| Risk | Avg | |
| Return | Avg |
| Pretax Return | 6.13% |
|---|---|
| Tax-adjusted Return | 5.83% |
| Tax Cost Ratio | 0.28% |
| Potential Cap Gains | -34.82% |
